The global antimicrobial susceptibility test (AST) market is poised for a decade of rapid expansion, with its valuation projected to rise from USD 3.8 billion in 2025 to USD 8.3 billion by 2035. According to a comprehensive market analysis by Fact.MR, the industry is advancing at a compound annual growth rate (CAGR) of 8.1%, fueled by a global mandate to combat...
The escalating threat of antimicrobial resistance (AMR) is driving a critical expansion in the diagnostic sector, as healthcare providers seek faster and more accurate ways to determine effective treatments. The Antimicrobial Susceptibility Testing Market was valued at USD 4.24 billion in 2024 and is expected to reach USD 6.68 billion by 2032, growing at a CAGR of...
The escalating threat of antimicrobial resistance (AMR) is driving a critical expansion in the diagnostic sector, as healthcare providers seek faster and more accurate ways to determine effective treatments. The Antimicrobial Susceptibility Testing Market was valued at USD 4.24 billion in 2024 and is expected to reach USD 6.68 billion by 2032, growing at a CAGR of...
The escalating threat of antimicrobial resistance (AMR) is driving a critical expansion in the diagnostic sector, as healthcare providers seek faster and more accurate ways to determine effective treatments. The Antimicrobial Susceptibility Testing Market was valued at USD 4.24 billion in 2024 and is expected to reach USD 6.68 billion by 2032, growing at a CAGR of...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek